Medtronic Engages Leading Digital and Healthcare Technology Leaders to Drive Business Transformation

“We are taking bold steps to become the leader in healthcare technology and be a destination for world-class talent,” said Geoff marthe, Chairman and CEO of Medtronic. “These executive appointments bring outside thinking, new skills and capabilities, and diverse perspectives to our already talented leadership team – and will continue to fuel Medtronic’s transformation.

Bob hopkins, responsible for global strategy
Hopkins will join as head of global strategy. Hopkins is from Bank of America Merrill Lynch, where he has been Managing Director since 2008, covering the medical technology industry, including Medtronic. Hopkins has worked with the medical technology industry for over 25 years. He has been the # 1 industry analyst for the past three years in Institutional Investor’s annual survey, and has been in the top three for the past 17 years.

In his role, Hopkins will partner with senior management at Medtronic in the areas of strategy, business development, capital deployment and investor communications. Its broad global perspective, including information on companies, technologies and trends impacting the healthcare and medical technology industry, will help Medtronic continue to navigate the rapidly changing industry.

Mei Jiang, head of global digital innovation
Jiang will join Medtronic from Iron Mountain, where she was Senior Vice President, Global Head of Innovation, Products and Solutions.

Prior to Iron Mountain, Jiang spent six years at HP, where she most recently served as Head of Digital Innovation and Business Transformation, and at Cisco, where she was Founder / CEO of a consulting startup. management. Since 2000, she has led three startups towards accelerated growth and served on several boards of directors for startups in Silicon Valley.

Jiang is also a member of the Forbes Technology Council and a founding member of “Chief”; a private network designed for women leaders (increasingly VP to CEO) in order to strengthen their experience within the C-suite.

In his new role, Jiang will work with leaders across the organization to test, scale and accelerate Medtronic’s data, digitization and AI strategies, globally. This work includes using data and AI to improve internal processes, as well as establishing new business models that take advantage of existing capabilities and technologies. It will transform key business markets and activities using insights from data and AI, and establish the enterprise-wide capabilities and resources needed to support this transformation.

Harry “Skip” Kiil, President, Cranial and Spinal Technologies Business Unit
Kiil will join Medtronic from Smith + Nephew, where he was President of the Global Orthopedics Division, responsible for the company’s reconstructive arthroplasty, robotics, trauma and extremity businesses. Kiil has extensive experience in the field of spine and orthopedics, a deep understanding of international markets, and expertise in harnessing technology to create and deliver an integrated ecosystem at scale.

Previously, Kiil was Executive Vice President and President of Global Business Operations at NuVasive, Inc. He was also Chief of Surgery, Europe, Middle East, Africa, and Russia, in the Alcon Eye Care division of Novartis Corporation, where he was responsible for leading the business transformation of the surgical business in developed and emerging growth markets. Prior to joining Alcon, Kiil spent 12 years with Stryker Corporation, where he held a number of executive roles, including that of Vice President and General Manager of Europe, and managing director of Japan.

In his new role, Kiil will be responsible for driving innovation and delivering therapies to markets around the world faster and more efficiently and cultivating a strong culture within Cranial and Spinal Technologies.

Mira Sahney, President, Pelvic Health Operational Unit
Sahney brings over 25 years of executive leadership experience in the development and commercialization of innovative medical technologies in gynecology, ENT, orthopedics and medical robotics. Sahney will leverage his in-depth knowledge of mergers and acquisitions, product marketing and business strategy to lead Pelvic Health’s business unit into the increasingly competitive future of the incontinence market.

Sahney joins Medtronic after working at Hyalex Orthopedics, a medical device start-up based in Lexington, Massachusetts – where she has been Chief Executive Officer and member of the Board of Directors since 2017. In this capacity, she formed her investment syndicate and built a world-class organization.

Prior to Hyalex, Sahney held several leadership roles at Smith + Nephew, including Senior Vice President and General Manager of ENT and Gynecology. She also led the sale of Smith + Nephew’s gynecology business to Medtronic in 2016.

Prior to her tenure at Smith + Nephew, Sahney was President, CEO and Co-Founder of Myomo, Inc., an award-winning medical robotics startup that went public in 2017. Her early career included a variety of supply chains , engineering, strategy, product management, product development, research and software roles at Flow International, the BMW Group and Boeing.

In his new role, Sahney will be responsible for driving innovation and expanding access to more patients globally, while cultivating a strong culture within Pelvic Health.

About Medtronic
Bold thinking. More daring actions. We are Medtronic. Medtronic plc, headquartered at Dublin, Ireland, is the leading global health technology company boldly tackling the most difficult health problems facing humanity by seeking and finding solutions. Our mission – to relieve pain, restore health and extend life – unites a global team of more than 90,000 passionate people in 150 countries. Our technologies and therapies address 70 health issues and include cardiac devices, surgical robots, insulin pumps, surgical tools, patient monitoring systems, and more. Armed with our diverse knowledge, insatiable curiosity, and desire to help anyone in need, we deliver innovative technologies that transform the lives of two people every second, hour, day. Expect more from us as we empower insight-driven care, people-first experiences, and better outcomes for our world. In everything we do, we design the extraordinary. For more information on Medtronic (NYSE: MDT), visit and follow @Medtronic on Twitter and LinkedIn.

Any forward-looking statement is subject to risks and uncertainties such as those described in Medtronic’s periodic reports filed with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.


Erika winkels

Ryan weispfenning

Public relations

Investor Relations

+ 1-763-526-8478

+ 1-763-505-4626

SOURCE Medtronic plc

Related links

Comments are closed.